Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amylin Obesity Combo Scores Big Weight Loss In Phase IIa Trial

Nov 15 2007

• By Shirley Haley

Related Content

Amylin’s Symlin Diabetes Therapy Gets FDA Nod

Mar 16 2005

Amylin’s SymlinPen To Launch In December

Oct 01 2007

Amylin/Lilly’s Once-Weekly Exenatide Wins Head-To-Head Over Byetta

Oct 31 2007

Arena’s Lorcaserin Can Continue To Bloom In Phase III Obesity Trial

Sep 11 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window